Moderna Aktie 44811242 / US60770K1079
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
27.12.2025 16:10:00
|
Forget Moderna Stock, This is a Much Better Buy
Investors flocked to Moderna (NASDAQ: MRNA) stock in the early days of the pandemic for one big reason: The company sold one of the world's most-needed products, a coronavirus vaccine. The vaccine brought in billions of dollars of revenue, and with this first product, Moderna went from a clinical-stage biotech to a highly profitable commercial-stage company in a matter of months.Though Moderna stock soared back then, in more recent times, the stock has stumbled. The company has seen vaccine sales decline, and its second big product -- its respiratory syncytial virus (RSV) vaccine -- hasn't performed as well as expected when it comes to delivering growth. Still, Moderna has made progress on cost cuts and has refocused its pipeline on several promising programs. And investors may be taking notice. The stock has climbed more than 30% over the past month.But, if you're looking to invest in a surefire biotech winner, forget Moderna stock. The following player is a much better buy...Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Nachrichten zu Moderna Inc
|
01.01.26 |
S&P 500-Papier Moderna-Aktie: So viel Verlust hätte ein Moderna-Investment von vor 5 Jahren eingefahren (finanzen.ch) | |
|
31.12.25 |
Mittwochshandel in New York: S&P 500 verliert letztendlich (finanzen.ch) | |
|
31.12.25 |
Angespannte Stimmung in New York: S&P 500 gibt nachmittags nach (finanzen.ch) | |
|
31.12.25 |
Zurückhaltung in New York: S&P 500 präsentiert sich mittags schwächer (finanzen.ch) | |
|
30.12.25 |
Schwache Performance in New York: S&P 500 zum Ende des Dienstagshandels in der Verlustzone (finanzen.ch) | |
|
26.12.25 |
Schwacher Handel in New York: S&P 500 beendet die Freitagssitzung mit Verlusten (finanzen.ch) | |
|
26.12.25 |
Minuszeichen in New York: S&P 500 verliert (finanzen.ch) | |
|
26.12.25 |
Freitagshandel in New York: S&P 500 notiert im Minus (finanzen.ch) |